Veracyte touts results of Percepta genomic sequencing study
January 25, 2022 -- Veracyte has released data from a study that used the company's Percepta genomic sequencing classifier, which the company reported can deliver curative therapy for patients with high-risk lung nodules and inconclusive bronchoscopy results. Read More
Illumina to collaborate with Japan's National Cancer Center
January 24, 2022 -- Illumina and Japan's National Cancer Center have announced a collaboration that will use Illumina's DNA sequencing assay TruSight Oncology 500 ctDNA to analyze the blood-based profile of nasopharyngeal cancer. Read More
PierianDx, Biodesix partner on lung cancer diagnostics
January 19, 2022 -- PierianDx and Biodesix announced that they will be partnering in the development of lung cancer diagnostics based on next-generation sequencing technology. Read More
Lab owner pleads guilty to fraud charge for genetic tests
January 14, 2022 -- A Florida man who ran a genetics testing lab has pleaded guilty to one charge of healthcare fraud related to accusations that he paid kickbacks and bribes to physicians for referring patients for unnecessary lab tests. Read More
Agendia, Illumina partner on genomic testing for breast cancer
January 11, 2022 -- Precision oncology firm Agendia has announced a multiyear partnership with Illumina to co-develop IVD tests for oncology testing. The companies aim to bring improved insights to patients with breast cancer, Agendia said. Read More
Guardant Health, Foundation Medicine reach settlement
January 10, 2022 -- Precision oncology company Guardant Health and Foundation Medicine have agreed to settle pending litigation concerning Guardant patents for digital sequencing technology. Read More
Pillar's NGS lab receives certification, state permit
January 10, 2022 -- Pillar Biosciences' next-generation sequencing (NGS) laboratory has passed onsite inspection and recently received certification from the U.S. Department of Health and Human Services' Centers for Medicare and Medicaid Services, the company said. Read More
Nucleix advances EpiCheck lung cancer platform
January 6, 2022 -- Nucleix has announced promising research findings in its EpiCheck next-generation sequencing platform for detecting early-stage lung cancer. The company also announced it recently secured new funding. Read More
AI should assist clinicians during patient diagnostic journey
January 3, 2022 -- To realize the full potential of artificial intelligence (AI) in diagnostics, it is time to develop a new generation of tools that assist clinicians during a patient's path to diagnosis rather than tools that predict final diagnoses, asserts a viewpoint published on December 28 in JAMA. Read More
Labcorp to acquire Personal Genome Diagnostics
December 23, 2021 -- Labcorp has announced that it has entered into an agreement to acquire Personal Genome Diagnostics, a cancer genomics firm with a portfolio of liquid biopsy and tissue-based products. Read More